[1]
“A comparative study between efficacy and safety of telmisartan (ARB) and enlapril (ACEI) in hypertensive patients”, Int. J. of Res. in Pharmacology &Pharmacotherapeutics , vol. 8, no. 2, pp. 142–147, Apr. 2021, doi: 10.61096/ijrpp.v8.iss2.2019.142-147.